Seattle Genetics | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 60.34B 1.83B 2024-12
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
Astellas Pharma JPY 564.89B 20.62B 2025-03
Bayer EUR 35.02B 468M 2025-03
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Celldex Therapeutics USD 0 0 2025-03
Daiichi Sankyo JPY 100.93B 95M 2025-03
Eisai JPY 99.83B 9M 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Exelixis USD 0 0 2025-04
Genmab DKK 129M 808M 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 32.64M 899K 2025-03
Insmed USD 1.13B 888K 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 33.48B 978M 2025-03
Moderna USD 35M 4M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.64B 234M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 13.41B 1.62B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Takeda JPY 3.97T 738.36B 2025-03
Teva Pharmaceutical Industries USD 16.23B 228M 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 101.84M 13.32M 2025-03



Seattle Genetics Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.